BioCentury

BioCentury This Week

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Glöm inte att besöka poddens webbplats och stötta skaparen: www.biocentury.com

Skapare

BioCentury

Kategori

Science

Poddens webbplats

www.biocentury.com

Senaste avsnittet

13 okt 2026

Var kan du lyssna?

Poddar i appen Replaio Radio Kommer snart

Poddar kommer snart till appen. Installera nu och bli först med att uppleva ett helt nytt sätt att lyssna på poddar

Ladda ned på Google Play Installera gratis Android nästan 10 mn nedladdningar · betyg 4,8 iOS snart

Avsnitt

Ep 76 Pt. 2 - Standards of Evidence for Accelerated Approval 30.08.2021

Reach us by sending a text

Ep 76 Pt. 1 - Accelerated Approval's Big Picture 30.08.2021

Reach us by sending a text

Ep. 75 - Back to School Preview, plus Pfizer Eats Trillium 24.08.2021

Reach us by sending a text

Ep. 74 - Vertex's Road Map & Innovation in MS 16.08.2021

Reach us by sending a text

Ep. 73 - Next Up in COVID with Otello Stampacchia and Umer Raffat 13.08.2021

Reach us by sending a text

Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD 09.08.2021

Reach us by sending a text

Ep. 71 - Lessons from China’s Market Turmoil, Plus Distillery on Tap 03.08.2021

Reach us by sending a text

Ep. 70 - Prepping for China’s IP law with Jones Day’s Tony Chen 29.07.2021

Reach us by sending a text

Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer 27.07.2021

Reach us by sending a text

Ep. 68 - Drug Pricing Pressure, Plus European Deal Trends 20.07.2021

Reach us by sending a text

Ep. 67 - Aduhelm: a Tangled Plot; Plus, INTREPID Pandemic Planning 13.07.2021

Reach us by sending a text

Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap 06.07.2021

Reach us by sending a text

Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm 29.06.2021

Reach us by sending a text

Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint 24.06.2021

Reach us by sending a text

Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast 21.06.2021

Reach us by sending a text

Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast 14.06.2021

Reach us by sending a text

Ep. 61 - Dissecting FDA's Aducanumab Decision 08.06.2021

Reach us by sending a text

Ep. 60 - D-Day for Aducanumab: What's at stake 02.06.2021

Reach us by sending a text

Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR 02.06.2021

Reach us by sending a text

Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights 24.05.2021

Reach us by sending a text

Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays 10.05.2021

Reach us by sending a text

Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe 04.05.2021

Reach us by sending a text

Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial 27.04.2021

Reach us by sending a text

Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality 20.04.2021

Reach us by sending a text

Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview 13.04.2021

Reach us by sending a text

Lyssna på podden BioCentury This Week i Replaio

Radio och poddar i en och samma app - gratis och utan konto. Installera redan idag och missa inte premiären

Ladda ned på Google Play

Replaio är ingen poddutgivare; programnamn, omslag och ljud tillhör sina upphovspersoner och distribueras via offentliga RSS-flöden